COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic

In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.

[1]  S. Spector,et al.  Stinging insect hypersensitivity , 2004 .

[2]  D. Bernstein,et al.  Stinging insect hypersensitivity: A practice parameter update 2016. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  S. Opal,et al.  Middle East respiratory syndrome (MERS) , 2014, Virulence.

[4]  D. Bernstein,et al.  AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report. , 2017, The journal of allergy and clinical immunology. In practice.

[5]  L. Feenan,et al.  An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  Chitra Dinakar,et al.  American College of Allergy, Asthma & Immunology Position Paper on the Use of Telemedicine for Allergists. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  D. Stukus How Dr Google Is Impacting Parental Medical Decision Making. , 2019, Immunology and allergy clinics of North America.

[8]  J. Sheikh,et al.  The diagnosis and management of acute and chronic urticaria: 2014 update. , 2014, The Journal of allergy and clinical immunology.

[9]  G. Marshall The status of US allergy/immunology physicians in the 21st century: a report from the American Academy of Allergy, Asthma & Immunology Workforce Committee. , 2007, The Journal of allergy and clinical immunology.

[10]  Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020 , 2020, Journal of Korean medical science.

[11]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[12]  J. Portnoy,et al.  Telemedicine is as effective as in-person visits for patients with asthma. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  Tangchun Wu,et al.  Prevalence, risk factors, and management of asthma in China: a national cross-sectional study , 2019, The Lancet.

[14]  W. Guan,et al.  Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review , 2018, Archives of Virology.

[15]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[16]  J. Oppenheimer,et al.  Estimation of Health and Economic Benefits of Clinic Versus Home Administration of Omalizumab and Mepolizumab. , 2020, The journal of allergy and clinical immunology. In practice.

[17]  Joint Task Force on Practice Parameters Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  A. Farmer,et al.  Interactive telemedicine: effects on professional practice and health care outcomes. , 2015, The Cochrane database of systematic reviews.

[19]  Tania Elliott,et al.  Direct to Consumer Telemedicine , 2019, Current Allergy and Asthma Reports.

[20]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[21]  S. Spector,et al.  Allergen immunotherapy: a practice parameter third update. , 2007, The Journal of allergy and clinical immunology.

[22]  Beijing China. Prevention,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China , 2020 .

[23]  A. Ramsey,et al.  The Use of Telemedicine for Penicillin Allergy Skin Testing. , 2018, The journal of allergy and clinical immunology. In practice.

[24]  Pei Gao,et al.  Chronic obstructive pulmonary disease in China: a nationwide prevalence study , 2018, The Lancet Respiratory Medicine.

[25]  J. Portnoy,et al.  Tips for Seeing Patients via Telemedicine , 2018, Current Allergy and Asthma Reports.

[26]  A. Ponsonby,et al.  An Australian Consensus on Infant Feeding Guidelines to Prevent Food Allergy: Outcomes From the Australian Infant Feeding Summit. , 2017, The journal of allergy and clinical immunology. In practice.

[27]  Jyh-Chong Liang,et al.  Health Information Obtained From the Internet and Changes in Medical Decision Making: Questionnaire Development and Cross-Sectional Survey , 2018, Journal of medical Internet research.

[28]  D. Lang,et al.  Biologic Therapy in the Treatment of Chronic Skin Disorders. , 2017, Immunology and allergy clinics of North America.

[29]  B. Hagberg,et al.  CLINICAL CHARACTERISTICS , 1972 .

[30]  John Baker,et al.  Telemedicine Technology: a Review of Services, Equipment, and Other Aspects , 2018, Current Allergy and Asthma Reports.

[31]  J. Baillie,et al.  Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.

[32]  J. Portnoy,et al.  Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters , 2017, Annals of Internal Medicine.

[33]  Donald Trump,et al.  Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak , 2020 .

[34]  C. Charles,et al.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). , 1997, Social science & medicine.

[35]  D. Goh,et al.  Childhood severe acute respiratory syndrome, coronavirus infections and asthma , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[36]  C. Barbas,et al.  Severe Acute Respiratory Distress Syndrome , 2018, Advances in Extra-corporeal Perfusion Therapies.

[37]  H. Williams,et al.  Dietary exclusions for established atopic eczema. , 2008, The Cochrane database of systematic reviews.

[38]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[39]  M. Greenhawt,et al.  Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction , 2019, JAMA network open.

[40]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[41]  J. Oppenheimer,et al.  Immunomodulators and Biologics: Beyond Stepped-Care Therapy. , 2019, Clinics in chest medicine.

[42]  C. del Rio,et al.  COVID-19-New Insights on a Rapidly Changing Epidemic. , 2020, JAMA.

[43]  Rajaa Al-Raddadi,et al.  Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome , 2017, American journal of respiratory and critical care medicine.

[44]  M. Greenhawt,et al.  Update on penicillin allergy delabeling. , 2020, Current opinion in pediatrics.

[45]  S. Savic,et al.  Home self‐administration of omalizumab for chronic spontaneous urticaria , 2016, The British journal of dermatology.

[46]  R. Thomson,et al.  Shared Decision Making: A Model for Clinical Practice , 2012, Journal of General Internal Medicine.

[47]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[48]  D. Fleischer,et al.  “To screen or not to screen”: Comparing the health and economic benefits of early peanut introduction strategies in five countries , 2018, Allergy.

[49]  James O. Lloyd-Smith,et al.  Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 , 2020, medRxiv.

[50]  David M Lang,et al.  Utility of routine laboratory testing in management of chronic urticaria/angioedema. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[51]  M. Barry Shared Decision Making: Informing and Involving Patients to Do the Right Thing in Health Care , 2012, The Journal of ambulatory care management.

[52]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[53]  J. Oppenheimer,et al.  Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-effectiveness Analysis. , 2019, The journal of allergy and clinical immunology. In practice.

[54]  S. Spector,et al.  Stinging insect hypersensitivity: a practice parameter update. , 2004, The Journal of allergy and clinical immunology.

[55]  J. Portnoy,et al.  Telemedicine and emerging technologies for health care in allergy/immunology. , 2020, The Journal of allergy and clinical immunology.